. .. Discussion,

. .. Sur-la-cohorte,

. .. Les-complications, , p.61

F. A. La and .. .. ,

. .. Conclusion,

. .. Bibliographie,

.. .. Serment-d'hippocrate,

F. A. Dans-le-groupe and L. Taux,

, p = 0,43) et à J8, pp.68-96

, Si on observe l'amylase maximale, quel que soit le jour du dosage, la médiane dans le groupe FA était à 100 [54; 1397] U/L, significativement plus haute que dans le groupe sans fistule, p.40

. U/l;-p-<0, , p.1

, Ainsi un seuil d'amylase à 24 U/L en post-opératoire, peu importe le jour du dosage, permettait de prédire la survenue d'une FA avec une spécificité de 78% et une sensibilité de 82%. La CRP à J4 (figure 11B)

R. A. Armstrong, G. M. Carrera, and J. B. Blalock, Adenocarcinoma of the middle third of the esophagus arising from ectopic gastric mucosa, J Thorac Surg, vol.37, issue.3, pp.398-403, 1959.

J. Ferlay, I. Soerjomataram, R. Dikshit, S. Eser, C. Mathers et al., Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012: Globocan 2012, Int J Cancer, vol.136, issue.5, pp.359-86, 2015.

B. Gupta and N. Kumar, Worldwide incidence, mortality and time trends for cancer of the oesophagus, Eur J Cancer Prev, vol.26, issue.2, pp.107-125, 2017.

F. Binder-foucard, N. Bossard, P. Delafosse, A. Belot, A. Woronoff et al.,

, Cancer incidence and mortality in France over the 1980-2012 period: Solid tumors. Rev DÉpidémiologie Santé Publique, vol.62, pp.95-108, 2014.

P. C. Enzinger, Esophageal Cancer, N Engl J Med, vol.12, 2003.

D. C. Farrow, T. L. Vaughan, C. Sweeney, M. D. Gammon, W. H. Chow et al.,

, Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control CCC, vol.11, pp.231-239, 2000.

B. Er?ss, N. Farkas, Á. Vincze, B. Tinusz, L. Szapáry et al., Helicobacter pylori infection reduces the risk of Barrett's esophagus: A meta-analysis and systematic review

. Helicobacter, , vol.23, p.12504, 2018.

M. F. Vaezi, J. J. Vicari, and T. W. Rice, CagA-Positive Strains of Helicobacter pylori May Protect Against Barrett's Esophagus, vol.95, p.6, 2000.

L. A. Fischbach, H. Nordenstedt, J. R. Kramer, S. Gandhi, S. Dick-onuoha et al.,

, The Association Between Barrett's Esophagus and Helicobacter pylori Infection: A Meta-Analysis: Association Between Barrett's Esophagus and Helicobacter pylori Infection

, Helicobacter, vol.17, issue.3, pp.163-75, 2012.

C. De-martel, J. Ferlay, S. Franceschi, J. Vignat, F. Bray et al., Global burden of cancers attributable to infections in 2008: a review and synthetic analysis, Lancet Oncol

W. J. Blot, Rising Incidence of Adenocarcinoma of the Esophagus and nGastric Cardia

, JAMA J Am Med Assoc, vol.265, issue.10, p.1287, 1991.

A. Tan and F. Macrae, Management of cancer risk in Barrett's esophagus: Cancer in Barrett's esophagus, J Gastroenterol Hepatol, vol.26, issue.10, pp.1485-92, 2011.

P. Sharma, J. Dent, D. Armstrong, J. Bergman, L. Gossner et al., The development and validation of an endoscopic grading system for Barrett's esophagus: the

. Prague-c-&-m-criteria and . Gastroenterology, , vol.131, pp.1392-1401, 2006.

B. Weusten, R. Bisschops, E. Coron, M. Dinis-ribeiro, J. Dumonceau et al., Endoscopic management of Barrett's esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy, vol.49, pp.191-199, 2017.

N. Modiano and L. B. Gerson, Barrett's esophagus: Incidence, etiology, pathophysiology, prevention and treatment. Ther Clin Risk Manag, vol.3, pp.1035-145, 2007.

A. Rastogi, S. Puli, H. B. El-serag, A. Bansal, S. Wani et al., Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis

, Gastrointest Endosc, vol.67, issue.3, pp.394-402, 2008.

C. Chang, P. Lao-sirieix, V. Save, D. Mendez, G. Laskey et al.,

, Retinoic acid-induced glandular differentiation of the oesophagus, Gut, vol.56, issue.7, pp.906-923, 2007.

H. B. El-serag, S. Sweet, C. C. Winchester, and J. Dent, Update on the epidemiology of gastrooesophageal reflux disease: a systematic review, Gut, vol.63, issue.6, pp.871-80, 2014.

J. Lagergren, R. Bergström, A. Lindgren, and O. Nyrén, Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma, N Engl J Med, vol.340, issue.11, pp.825-856, 1999.

V. K. Sharma, Role of endoscopy in GERD, Gastroenterol Clin North Am, 2014.

F. K. Friedenberg, M. Xanthopoulos, G. D. Foster, and J. E. Richter, The association between gastroesophageal reflux disease and obesity, Am J Gastroenterol, vol.103, issue.8, pp.2111-2133, 2008.

J. L. Petrick, S. P. Kelly, L. M. Liao, N. D. Freedman, B. I. Graubard et al., Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies, Br J Cancer, vol.116, issue.7, pp.951-960, 2017.

H. G. Coleman, S. Xie, and J. Lagergren, The Epidemiology of Esophageal Adenocarcinoma, Gastroenterology, vol.154, issue.2, pp.390-405, 2018.

J. Lagergren, Influence of obesity on the risk of esophageal disorders, Nat Rev Gastroenterol Hepatol, vol.8, issue.6, pp.340-347, 2011.

B. Lindkvist, D. Johansen, T. Stocks, H. Concin, T. Bjørge et al., Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project, BMC Cancer, vol.14, p.103, 2014.

B. J. Kendall, J. H. Rubenstein, M. B. Cook, T. L. Vaughan, L. A. Anderson et al.,

, Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis, Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc, vol.14, issue.10, pp.1412-1419, 2016.

M. B. Cook, F. Kamangar, D. C. Whiteman, N. D. Freedman, M. D. Gammon et al., Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium, J Natl Cancer Inst, vol.102, issue.17, pp.1344-53, 2010.

A. M. Kaz, C. Wong, V. Varadan, J. E. Willis, A. Chak et al., Global DNA methylation patterns in Barrett's esophagus, dysplastic Barrett's, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use, Clin Epigenetics, vol.8, p.111, 2016.

Q. Wang, S. Xie, W. Li, and J. Lagergren, Smoking Cessation and Risk of Esophageal Cancer by Histological Type: Systematic Review and Meta-analysis, J Natl Cancer Inst, 2017.

Q. Dai, M. M. Cantwell, L. J. Murray, W. Zheng, L. A. Anderson et al., Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study, Br J Nutr, vol.115, issue.2, pp.342-50, 2016.

S. C. Moore, I. Lee, E. Weiderpass, P. T. Campbell, J. N. Sampson et al.,

, Association of Leisure-Time Physical Activity With Risk of 26 Types of Cancer in 1.44 Million Adults, JAMA Intern Med, vol.176, issue.6, pp.816-841, 201601.

J. Lagergren and F. Mattsson, No further increase in the incidence of esophageal adenocarcinoma in Sweden, Int J Cancer, vol.129, issue.2, pp.513-519, 2011.

C. Y. Kong, S. Kroep, K. Curtius, W. D. Hazelton, J. Jeon et al., Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling, Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol, vol.23, issue.6, pp.997-1006, 2014.

L. A. Anderson, A. Tavilla, H. Brenner, S. Luttmann, C. Navarro et al., Survival for oesophageal, stomach and small intestine cancers in Europe 1999-2007: Results from EUROCARE-5, Eur J Cancer, vol.51, issue.15, pp.2144-57, 2015.

G. Launoy, N. Bossard, C. Castro, and S. Manfredi, Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study, Eur J Cancer Prev, vol.26, pp.24-31, 2017.

M. Di-pietro, M. I. Canto, and R. C. Fitzgerald, Endoscopic Management of Early Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus: Screening, Diagnosis, and Therapy. Gastroenterology, vol.154, pp.421-457, 2018.

N. J. Shaheen, Upper Endoscopy for Gastroesophageal Reflux Disease: Best Practice Advice From the Clinical Guidelines Committee of the American College of Physicians, Ann Intern Med, vol.157, issue.11, p.808, 2012.

K. H. Fuchs, B. Babic, W. Breithaupt, B. Dallemagne, A. Fingerhut et al., EAES recommendations for the management of gastroesophageal reflux disease, Surg Endosc, 2014.

N. Vakil, S. V. Van-zanten, P. Kahrilas, J. Dent, and R. Jones, Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidencebased consensus, Am J Gastroenterol, vol.101, issue.8, pp.1900-1920, 2006.

J. Dong, M. F. Buas, P. Gharahkhani, B. J. Kendall, L. Onstad et al., Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants, Gastroenterology, vol.154, issue.5, pp.1273-1281, 2018.

T. Benaglia, L. D. Sharples, R. C. Fitzgerald, and G. Lyratzopoulos, Health Benefits and Cost Effectiveness of Endoscopic and Nonendoscopic Cytosponge Screening for Barrett's Esophagus. Gastroenterology, 2013.

N. J. Shaheen, G. W. Falk, P. G. Iyer, and L. B. Gerson,

. Acg-clinical-guideline, Diagnosis and Management of Barrett's Esophagus, Am J Gastroenterol, vol.111, issue.1, pp.30-50, 2016.

M. B. Sturm and T. D. Wang, Emerging optical methods for surveillance of Barrett's oesophagus, Gut, vol.64, issue.11, pp.1816-1839, 2015.

R. Mallick, S. K. Patnaik, S. Wani, and A. Bansal, A Systematic Review of Esophageal

, MicroRNA Markers for Diagnosis and Monitoring of Barrett's Esophagus, Dig Dis Sci, 2016.

P. Lao-sirieix, A. Boussioutas, S. R. Kadri, M. O'donovan, I. Debiram et al., Nonendoscopic screening biomarkers for Barrett's oesophagus: from microarray analysis to the clinic, Gut, vol.58, issue.11, pp.1451-1460, 2009.

S. R. Kadri, P. Lao-sirieix, O. 'donovan, M. Debiram, I. Das et al.,

, Acceptability and accuracy of a non-endoscopic screening test for Barrett's oesophagus in primary care: cohort study, BMJ, vol.341, p.4372, 2010.

S. Kumar, J. Huang, N. Abbassi-ghadi, H. A. Mackenzie, K. A. Veselkov et al.,

, Mass Spectrometric Analysis of Exhaled Breath for the Identification of Volatile Organic Compound Biomarkers in Esophageal and Gastric Adenocarcinoma: Ann Surg, 2015.

A. Bhardwaj, C. S. Hollenbeak, N. Pooran, and A. Mathew, A meta-analysis of the diagnostic accuracy of esophageal capsule endoscopy for Barrett's esophagus in patients with gastroesophageal reflux disease, Am J Gastroenterol, vol.104, issue.6, pp.1533-1542, 2009.

T. W. Rice, D. T. Patil, and E. H. Blackstone, AJCC/UICC staging of cancers of the esophagus and esophagogastric junction: application to clinical practice. Ann Cardiothorac Surg, vol.6, pp.119-149, 2017.

T. W. Rice, H. Ishwaran, M. K. Ferguson, E. H. Blackstone, and P. Goldstraw, Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer, J Thorac Oncol

S. Kelly, K. M. Harris, E. Berry, J. Hutton, P. Roderick et al., A systematic review of the staging performance of endoscopic ultrasound in gastro-oesophageal carcinoma

, Gut, vol.49, issue.4, pp.534-543, 2001.

D. Yang, R. M. Coman, M. Kahaleh, I. Waxman, A. Y. Wang et al., Endoscopic submucosal dissection for Barrett's early neoplasia: a multicenter study in the United States

, Gastrointest Endosc, vol.86, issue.4, pp.600-607, 2017.

E. Bollschweiler, S. E. Baldus, W. Schröder, K. Prenzel, C. Gutschow et al.,

, High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas, Endoscopy, vol.38, issue.2, pp.149-56, 2006.

J. Dumonceau, P. Deprez, C. Jenssen, J. Iglesias-garcia, A. Larghi et al., Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline -Updated, Endoscopy, vol.49, issue.07, pp.695-714, 2017.

E. Van-vliet, M. H. Heijenbrok-kal, M. Hunink, E. J. Kuipers, P. D. Siersema et al., Evaluation of distant metastases in esophageal cancer: 100 consecutive positron emission tomography scans, Ann Thorac Surg, vol.98, issue.3, pp.1136-1137, 1999.

T. W. Rice, H. Ishwaran, E. H. Blackstone, W. L. Hofstetter, and D. P. Kelsen,

C. , Recommendations for clinical staging (cTNM) of cancer of the esophagus and esophagogastric junction for the 8th edition AJCC/UICC staging manuals, Dis Esophagus Off J Int Soc Dis Esophagus, vol.29, issue.8, pp.913-922, 2016.

H. Guo, X. Zhang, M. Chen, S. Huang, X. Zou et al.,

F. Sun, P. Yuan, T. Chen, and J. Hu, Efficacy and complication of endoscopic submucosal dissection for superficial esophageal carcinoma: a systematic review and meta-analysis, J Cardiothorac Surg, vol.9, p.78, 2014.

R. Siewert, J. Feith, M. Werner, M. Stein, and H. J. , Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients, Ann Surg, vol.232, issue.3, pp.353-61, 2000.

C. Mariette, G. Piessen, N. Briez, C. Gronnier, and J. P. Triboulet, Oesophagogastric junction adenocarcinoma: which therapeutic approach?, Lancet Oncol, vol.12, issue.3, pp.296-305, 2011.

F. Lordick, C. Mariette, K. Haustermans, R. Obermannová, and D. Arnold, Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up ?, Ann Oncol, vol.27, issue.suppl_5, pp.50-57, 2016.

R. P. Merkow, K. Y. Bilimoria, R. N. Keswani, J. Chung, K. L. Sherman et al.,

, Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer

, J Natl Cancer Inst, vol.106, issue.7, 2014.

K. M. Sjoquist, B. H. Burmeister, B. M. Smithers, J. R. Zalcberg, R. J. Simes et al.,

, Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis, Lancet Oncol, vol.12, issue.7, pp.681-92, 2011.

J. Shapiro, J. Van-lanschot, M. Hulshof, P. Van-hagen, and . Van-berge-henegouwen,

W. Mi and . Bpl, Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial, Lancet Oncol, vol.16, issue.9, pp.1090-1098, 2015.

W. H. Allum, S. P. Stenning, J. Bancewicz, P. I. Clark, and R. E. Langley,

, Randomized Trial of Surgery With or Without Preoperative Chemotherapy in Esophageal Cancer, J Clin Oncol, vol.27, issue.30, pp.5062-5069, 2009.

A. Homann, N. Pauligk, C. Goetze, T. O. Meiler, J. Kasper et al.,

, Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial, Lancet Lond Engl, vol.393, pp.1948-57, 10184.

E. C. Smyth, M. Verheij, W. Allum, D. Cunningham, A. Cervantes et al., Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol Off J Eur Soc Med Oncol, vol.27, issue.5, pp.38-49, 2016.

A. Herskovic, K. Martz, M. Sarraf, L. Leichman, J. Brindle et al.,

, Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus, N Engl J Med, vol.326, issue.24, pp.1593-1601, 1992.

B. Filip, I. Hutanu, I. Radu, M. G. Anitei, and V. Scripcariu, Assessment of different prognostic scores for early postoperative outcomes after esophagectomy, Chir Buchar Rom, vol.109, issue.4, pp.480-485, 1990.

J. Robert and . Ginsberg, Cancer Treatment in the Elderly, J Am Coll Surg, 1998.

, United Nations, Department of Economic and Social Affairs, vol.187, pp.427-435

, World Population Ageing, 2013.

M. K. Ferguson, T. R. Martin, L. B. Reeder, and J. Olak, Mortality after Esophagectomy: Risk Factor Analysis, World J Surg, vol.21, issue.6, pp.599-604, 1997.

W. Schröder, E. Bollschweiler, C. Kossow, and A. H. Hölscher, Preoperative risk analysis-a reliable predictor of postoperative outcome after transthoracic esophagectomy? Langenbecks Arch Surg, vol.391, pp.455-60, 2006.

F. H. Ellis, W. A. Williamson, and G. J. Heatley, Cancer of the esophagus and cardia: does age influence treatment selection and surgical outcomes?, J Am Coll Surg, vol.187, issue.4, pp.345-51, 1998.

L. Bonavina, R. Incarbone, G. Saino, P. Clesi, and A. Peracchia, Clinical outcome and survival after esophagectomy for carcinoma in elderly patients, Dis Esophagus Off J Int Soc Dis Esophagus, vol.16, issue.2, pp.90-93, 2003.

E. Paulus, C. Ripat, V. Koshenkov, A. T. Prescott, K. Sethi et al., Esophagectomy for cancer in octogenarians: should we do it? Langenbecks Arch Surg, vol.402, pp.539-584, 2017.

H. Bartels, H. J. Stein, and J. R. Siewert, Preoperative risk analysis and postoperative mortality of oesophagectomy for resectable oesophageal cancer, Br J Surg, vol.85, issue.6, pp.840-844, 1998.

C. Mariette, G. Taillier, I. Van-seuningen, and J. Triboulet, Factors Affecting Postoperative Course and Survival After En Bloc Resection for Esophageal Carcinoma, Ann Thorac Surg

P. Mcculloch, Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study, BMJ, vol.327, issue.7425, pp.1192-1199, 2003.

M. M. Oken, R. H. Creech, D. C. Tormey, J. Horton, T. E. Davis et al., Toxicity and response criteria of the Eastern Cooperative Oncology Group, Am J Clin Oncol, 1982.

G. P. Copeland, D. Jones, and M. Walters, POSSUM: a scoring system for surgical audit, Br J Surg, vol.78, issue.3, pp.355-60, 1991.

, Prise en charge du coronarien opéré en chirurgie non cardiaque. Ann Fr Anesth Réanimation, vol.30, pp.5-29, 2011.

T. H. Lee, E. R. Marcantonio, C. M. Mangione, E. J. Thomas, C. A. Polanczyk et al.,

, Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation, vol.100, pp.1043-1052, 1999.

Y. Nagamatsu, I. Shima, H. Yamana, H. Fujita, K. Shirouzu et al.,

, Cardiovasc Surg, vol.121, issue.6, pp.1064-1072, 2001.

E. W. Steyerberg, B. A. Neville, L. B. Koppert, V. Lemmens, and H. W. Tilanus, Coebergh J

. Ww, Surgical Mortality in Patients With Esophageal Cancer: Development and Validation of a Simple Risk Score, J Clin Oncol, vol.24, issue.26, pp.4277-84, 2006.

F. Guarracino, R. Baldassarri, and H. J. Priebe, Revised ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management. Implications for preoperative clinical evaluation, Minerva Anestesiol, vol.81, issue.2, pp.226-259, 2015.

J. Hulscher, J. W. Van-sandick, P. P. Devriese, J. Van-lanschot, and H. Obertop,

, Br J Surg, vol.86, issue.12, pp.1583-1590, 1999.

H. Kuwano, K. Sumiyoshi, K. Sonoda, K. Kitamura, S. Tsutsui et al., Relationship between preoperative assessment of organ function and postoperative morbidity in patients with oesophageal cancer, Eur J Surg Acta Chir, vol.164, issue.8, pp.581-587, 1998.

C. E. Avendano, P. A. Flume, G. A. Silvestri, L. B. King, and C. E. Reed, Pulmonary complications after esophagectomy, Ann Thorac Surg, vol.73, issue.3, pp.922-928, 2002.

M. Katsura, A. Kuriyama, T. Takeshima, S. Fukuhara, and T. A. Furukawa, Preoperative inspiratory muscle training for postoperative pulmonary complications in adults undergoing cardiac and major abdominal surgery. Cochrane Anaesthesia, Critical and Emergency Care Group, editor. Cochrane Database Syst Rev, 2015.

,

K. Valkenet, J. Trappenburg, J. P. Ruurda, E. M. Guinan, J. V. Reynolds et al.,

, Multicentre randomized clinical trial of inspiratory muscle training versus usual care before surgery for oesophageal cancer: Inspiratory muscle training before surgery for oesophageal cancer, Br J Surg, vol.105, issue.5, pp.502-513, 2018.

C. Chambrier and F. Sztark, French clinical guidelines on perioperative nutrition. Update of the 1994 consensus conference on perioperative artificial nutrition for elective surgery in adults, J Visc Surg, vol.149, issue.5, pp.325-336, 2012.

H. Takeuchi, S. Ikeuchi, Y. Kawaguchi, Y. Kitagawa, Y. Isobe et al., Clinical Significance of Perioperative Immunonutrition for Patients with Esophageal Cancer, World J Surg, vol.31, issue.11, pp.2160-2167, 2007.

L. A. Healy, A. M. Ryan, B. Gopinath, S. Rowley, P. J. Byrne et al.,

, Thorac Cardiovasc Surg, vol.134, issue.5, pp.1284-91, 2007.

M. A. Morgan, W. G. Lewis, A. N. Hopper, X. Escofet, T. J. Harvard et al.,

C. Mariette, Is there a place for esogastric cancer surgery in cirrhotic patients?, Ann Surg Oncol, vol.15, issue.3, pp.680-682, 2008.

F. Fekete, J. Belghiti, D. Cherqui, F. Langonnet, and B. Gayet, Results of esophagogastrectomy for carcinoma in cirrhotic patients. A series of 23 consecutive patients, Ann Surg, 1987.

B. Dhungel, B. S. Diggs, J. G. Hunter, B. C. Sheppard, J. T. Vetto et al., Patient and perioperative predictors of morbidity and mortality after esophagectomy: American College of Surgeons National Surgical Quality Improvement Program, pp.2005-2008

, Gastrointest Surg Off J Soc Surg Aliment Tract, vol.14, issue.10, pp.1492-501, 2010.

B. Capron, H. L. Frêche, C. Mariette, and G. Lebuffe, Anesthésie-réanimation en chirurgie du cancer de l'oesophage, vol.14, 2018.

P. P. Tekkis, P. Mcculloch, J. D. Poloniecki, D. R. Prytherch, N. Kessaris et al., Riskadjusted prediction of operative mortality in oesophagogastric surgery with O-POSSUM, Br J Surg, vol.91, issue.3, pp.288-95, 2004.

M. K. Ferguson, A. D. Celauro, and V. Prachand, Prediction of major pulmonary complications after esophagectomy, Ann Thorac Surg, vol.91, issue.5, pp.1500-1501, 2011.

N. F. Noble, N. Curtis, S. Harris, J. J. Kelly, and I. S. Bailey, Risk Assessment Using a Novel Score to Predict Anastomotic Leak and Major Complications after Oesophageal Resection, J Gastrointest Surg, vol.16, issue.6, pp.1083-95, 2012.

S. Pasquali, G. Yim, R. S. Vohra, S. Mocellin, D. Nyanhongo et al., Survival After Neoadjuvant and Adjuvant Treatments Compared to Surgery Alone for Resectable Esophageal Carcinoma: A Network Meta-analysis, Ann Surg, vol.265, issue.3, pp.481-91, 2017.

S. R. Markar, C. Gronnier, A. Duhamel, A. Pasquer, J. Théreaux et al., Significance of Microscopically Incomplete Resection Margin After Esophagectomy for Esophageal Cancer: Ann Surg, vol.263, pp.712-720, 2016.

M. Sasako, T. Sano, S. Yamamoto, M. Sairenji, K. Arai et al., Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial, Lancet Oncol, vol.7, issue.8, pp.644-51, 2006.

J. Hulscher, J. W. Van-sandick, A. De-boer, B. Wijnhoven, J. Tijssen et al., Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus, N Engl J Med, vol.347, issue.21, pp.1662-1671, 2002.

K. L. Meredith, T. Maramara, P. Blinn, D. Lee, J. Huston et al., Comparative Perioperative Outcomes by Esophagectomy Surgical Technique, J Gastrointest Surg

, , 2019.

S. Biere, M. I. Van-berge-henegouwen, K. W. Maas, L. Bonavina, C. Rosman et al., Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial, Lancet Lond Engl, vol.379, issue.9829, pp.1887-92, 2012.

C. Mariette, S. Markar, T. S. Dabakuyo-yonli, B. Meunier, D. Pezet et al., Healthrelated Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial: The MIRO Trial, 111. van der Sluis PC, vol.13, p.230, 2012.

N. P. Rizk, H. Ishwaran, T. W. Rice, L. Chen, P. H. Schipper et al., Optimum Lymphadenectomy for Esophageal Cancer: Ann Surg, vol.251, pp.46-50, 2010.

A. Schandl, A. Johar, J. Lagergren, and P. Lagergren, Lymphadenectomy and health-related quality of life after oesophageal cancer surgery: a nationwide, population-based cohort study, BMJ Open, vol.6, issue.8, p.12624, 2016.

M. Anderegg, S. M. Lagarde, V. P. Jagadesham, S. S. Gisbertz, A. Immanuel et al., Prognostic Significance of the Location of Lymph Node Metastases in Patients With Adenocarcinoma of the Distal Esophagus or Gastroesophageal Junction: Ann Surg, 2016.

C. B. Begg, Impact of Hospital Volume on Operative Mortality for Major Cancer Surgery

J. , , vol.280, p.1747, 1998.

P. Feltracco, A. Bortolato, S. Barbieri, E. Michieletto, E. Serra et al., Perioperative benefit and outcome of thoracic epidural in esophageal surgery: a clinical review, Dis Esophagus [Internet], issue.5, p.31, 2018.

P. Michelet, D. Roch, A. Papazian, L. Ragni, J. Thomas et al., Perioperative Risk Factors for Anastomotic Leakage After Esophagectomy, Chest, vol.128, issue.5, pp.3461-3467, 2005.

S. Jamel, K. Tukanova, and S. R. Markar, The evolution of fast track protocols after oesophagectomy, J Thorac Dis, vol.11, issue.S5, pp.675-84, 2019.

Y. Ohkura, J. Shindoh, M. Ueno, T. Iizuka, S. Haruta et al., A new postoperative pain management (intravenous acetaminophen: Acelio®) leads to enhanced recovery after esophagectomy: a propensity score-matched analysis, Surg Today, vol.48, issue.5, pp.502-511, 2018.

K. T. Fjederholt, C. Okholm, L. B. Svendsen, M. P. Achiam, J. Kirkegård et al.,

, Ketorolac and Other NSAIDs Increase the Risk of Anastomotic Leakage After Surgery for GEJ Cancers: a Cohort Study of 557 Patients, J Gastrointest Surg, vol.22, issue.4, pp.587-94, 2018.

E. Chau and P. Slinger, Perioperative Fluid Management for Pulmonary Resection Surgery and Esophagectomy, Semin Cardiothorac Vasc Anesth, vol.18, issue.1, pp.36-44, 2014.

D. A. Reuter, M. Goepfert, T. Goresch, M. Schmoeckel, E. Kilger et al., Assessing fluid responsiveness during open chest conditions, Br J Anaesth, vol.94, issue.3, pp.318-341, 2005.

F. Piccioni, F. Bernasconi, G. Tramontano, and M. Langer, A systematic review of pulse pressure variation and stroke volume variation to predict fluid responsiveness during cardiac and thoracic surgery, J Clin Monit Comput, vol.31, issue.4, pp.677-84, 2017.

M. Kobayashi, M. Koh, T. Irinoda, E. Meguro, Y. Hayakawa et al., Stroke volume variation as a predictor of intravascular volume depression and possible hypotension during the early postoperative period after esophagectomy, Ann Surg Oncol, vol.16, issue.5, pp.1371-1378, 2009.

K. Oshima, F. Kunimoto, H. Hinohara, Y. Hayashi, Y. Kanemaru et al., Evaluation of respiratory status in patients after thoracic esophagectomy using PiCCO system

, Ann Thorac Cardiovasc Surg Off J Assoc Thorac Cardiovasc Surg Asia, vol.14, issue.5, pp.283-291, 2008.

T. Glatz, B. Kulemann, G. Marjanovic, S. Bregenzer, F. Makowiec et al.,

, Postoperative fluid overload is a risk factor for adverse surgical outcome in patients undergoing esophagectomy for esophageal cancer: a retrospective study in 335 patients, BMC Surg, 2017.

, Jan, vol.13, issue.1, p.6

H. J. Ahn, J. A. Kim, A. R. Lee, M. Yang, H. J. Jung et al., The Risk of Acute Kidney Injury from Fluid Restriction and Hydroxyethyl Starch in Thoracic Surgery, 2016.

H. Bahlmann, I. Halldestam, and L. Nilsson, Goal-directed therapy during transthoracic oesophageal resection does not improve outcome: Randomised controlled trial, Eur J Anaesthesiol, vol.36, issue.2, pp.153-61, 2019.

E. Klijn, S. Niehof, J. De-jonge, D. Gommers, C. Ince et al., The Effect of Perfusion Pressure on Gastric Tissue Blood Flow in an Experimental Gastric Tube Model: Anesth Analg, vol.110, pp.541-547, 2010.

R. Verhage, J. Boone, G. T. Rijkers, G. J. Cromheecke, A. C. Kroese et al.,

, Br J Anaesth, vol.112, issue.5, pp.920-928, 2014.

M. Licker, J. Diaper, Y. Villiger, A. Spiliopoulos, V. Licker et al., Impact of intraoperative lung-protective interventions in patients undergoing lung cancer surgery, Crit Care Lond Engl, vol.13, issue.2, p.41, 2009.

P. Michelet, D. Roch, A. Doddoli, C. Marin, V. Papazian et al., Protective ventilation influences systemic inflammation after esophagectomy: a randomized controlled study, Anesthesiology, vol.105, issue.5, pp.911-920, 2006.

C. Ferrando, A. Mugarra, A. Gutierrez, J. A. Carbonell, M. García et al., Setting Individualized Positive End-Expiratory Pressure Level with a Positive End-Expiratory Pressure Decrement Trial After a Recruitment Maneuver Improves Oxygenation and Lung Mechanics During One-Lung Ventilation, Anesth Analg, vol.118, issue.3, pp.657-65, 2014.

J. M. Findlay, E. Tustian, J. Millo, A. Klucniks, B. Sgromo et al., The effect of formalizing enhanced recovery after esophagectomy with a protocol: Enhanced recovery for esophagectomy, Dis Esophagus, vol.28, issue.6, pp.567-73, 2015.

J. M. Findlay, R. S. Gillies, J. Millo, B. Sgromo, R. Marshall et al., Enhanced Recovery for Esophagectomy: A Systematic Review and Evidence-Based Guidelines, Ann Surg, vol.259, issue.3, pp.413-444, 2014.

G. Berkelmans, L. Fransen, A. Dolmans-zwartjes, E. A. Kouwenhoven, M. J. Van-det et al., Direct Oral Feeding Following Minimally Invasive Esophagectomy (NUTRIENT II trial): An International, Multicenter, Open-label Randomized Controlled Trial

, Ann Surg, 2019.

M. Rutegård, P. Lagergren, I. Rouvelas, and J. Lagergren, Intrathoracic anastomotic leakage and mortality after esophageal cancer resection: a population-based study, Ann Surg Oncol

J. D. Luketich, M. Alvelo-rivera, P. O. Buenaventura, N. A. Christie, J. S. Mccaughan et al., Minimally invasive esophagectomy: outcomes in 222 patients, Ann Surg, 2003.

J. Bruce, Z. H. Krukowski, G. Al-khairy, E. M. Russell, and K. G. Park, Systematic review of the definition and measurement of anastomotic leak after gastrointestinal surgery, Br J Surg, 2001.

J. D. Luketich, A. Pennathur, O. Awais, R. M. Levy, S. Keeley et al., Outcomes After Minimally Invasive Esophagectomy: Review of Over 1000 Patients, Ann Surg, 2012.

J. Cools-lartigue, A. Andalib, A. Abo-alsaud, S. Gowing, M. Nguyen et al.,

, Ann Surg Oncol, vol.21, issue.8, pp.2573-2582, 2014.

J. E. Lantos, M. S. Levine, S. E. Rubesin, C. T. Lau, and D. A. Torigian, Comparison between esophagography and chest computed tomography for evaluation of leaks after esophagectomy and gastric pull-through, J Thorac Imaging, vol.28, issue.2, pp.121-129, 2013.

R. D. Page, A. Asmat, J. Mcshane, G. N. Russell, and S. H. Pennefather, Routine endoscopy to detect anastomotic leakage after esophagectomy, Ann Thorac Surg, vol.95, issue.1, pp.292-300, 2013.

E. Eizaguirre, S. Larburu, J. I. Asensio, A. Rodriguez, J. L. Elorza et al., Treatment of anastomotic leaks with metallic stent after esophagectomies: Stent anastomotic leaks esophagectomy, Dis Esophagus, vol.29, issue.1, pp.86-92, 2016.

J. W. Maher, W. Bakhos, N. Nahmias, L. G. Wolfe, J. G. Meador et al., Drain Amylase Levels Are an Adjunct in Detection of Gastrojejunostomy Leaks after Roux-en-Y Gastric Bypass, J Am Coll Surg, vol.208, issue.5, pp.881-885, 2009.

T. Davidson, M. Yaghoobi, B. R. Davidson, and K. S. Gurusamy, Amylase in drain fluid for the diagnosis of pancreatic leak in post-pancreatic resection. Cochrane Database Syst Rev, 2017.

, Apr, p.12009

S. B. Edge and C. C. Compton, The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM, Ann Surg Oncol, 2010.

, Acute Respiratory Distress Syndrome: The Berlin Definition, JAMA, 2012.

, , p.307

H. Abunasra, S. Lewis, L. Beggs, J. Duffy, D. Beggs et al., Predictors of operative death after oesophagectomy for carcinoma, Br J Surg, vol.92, issue.8, pp.1029-1062, 2005.

I. Gockel, C. Exner, and T. Junginger, Morbidity and mortality after esophagectomy for esophageal carcinoma: a risk analysis, World J Surg Oncol, vol.3, issue.1, p.37, 2005.

D. Mayhew, V. Mendonca, and B. Murthy, A review of ASA physical status -historical perspectives and modern developments, Anaesthesia, vol.74, issue.3, pp.373-382, 2019.

L. Goense, J. Meziani, J. P. Ruurda, and R. Van-hillegersberg, Impact of postoperative complications on outcomes after oesophagectomy for cancer, Br J Surg, 2018.

B. A. Yerokun, Z. Sun, C. Yang, B. C. Gulack, P. J. Speicher et al., Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Population-Based Analysis

, Ann Thorac Surg, vol.102, issue.2, pp.416-439, 2016.

I. Gockel, S. Niebisch, C. Ahlbrand, C. Hoffmann, M. Möhler et al., Risk and Complication Management in Esophageal Cancer Surgery: A Review of the Literature, Thorac Cardiovasc Surg, vol.64, issue.07, pp.596-605, 2015.

G. Marjanovic, C. Villain, E. Juettner, . Hausen-a-zur, J. Hoeppner et al., Impact of Different Crystalloid Volume Regimes on Intestinal Anastomotic Stability: Ann Surg, 2009.

, Feb, vol.249, issue.2, pp.181-186

H. M. Schmidt, S. S. Gisbertz, J. Moons, I. Rouvelas, J. Kauppi et al., Defining Benchmarks for Transthoracic Esophagectomy: A Multicenter Analysis of Total Minimally Invasive Esophagectomy in Low Risk Patients, Ann Surg, vol.266, issue.5, pp.814-835, 2017.

F. Klevebro, J. A. Elliott, A. Slaman, B. D. Vermeulen, S. Kamiya et al.,

, Cardiorespiratory Comorbidity and Postoperative Complications following Esophagectomy: a European Multicenter Cohort Study, 2019.

R. H. Kim and K. Takabe, Methods of esophagogastric anastomoses following esophagectomy for cancer: A systematic review, J Surg Oncol, vol.101, issue.6, pp.527-560, 2010.

E. H. Baker, J. S. Hill, M. K. Reames, J. Symanowski, S. C. Hurley et al., Drain amylase aids detection of anastomotic leak after esophagectomy, vol.7, p.8, 2016.

T. Nishigori, H. Miyata, H. Okabe, Y. Toh, H. Matsubara et al., Impact of hospital volume on risk-adjusted mortality following oesophagectomy in Japan: Hospital volume and mortality following oesophagectomy, Br J Surg, vol.103, issue.13, pp.1880-1886, 2016.

N. Brusselaers, F. Mattsson, and J. Lagergren, Hospital and surgeon volume in relation to long-term survival after oesophagectomy: systematic review and meta-analysis, Gut, 2014.

U. Zingg, B. M. Smithers, D. C. Gotley, G. Smith, A. Aly et al., Factors Associated with Postoperative Pulmonary Morbidity After Esophagectomy for Cancer, Ann Surg Oncol

A. R. Davies, J. A. Gossage, J. Zylstra, F. Mattsson, J. Lagergren et al., Tumor Stage After Neoadjuvant Chemotherapy Determines Survival After Surgery for Adenocarcinoma of the Esophagus and Esophagogastric Junction, J Clin Oncol, vol.32, issue.27, pp.2983-90, 2014.

S. Tandon, A. Batchelor, R. Bullock, A. Gascoigne, M. Griffin et al., Perioperative risk factors for acute lung injury after elective oesophagectomy, Br J Anaesth, 2001.

B. Z. Atkins, A. S. Shah, K. A. Hutcheson, J. H. Mangum, T. N. Pappas et al., Reducing hospital morbidity and mortality following esophagectomy, Ann Thorac Surg, 2004.

S. C. Murthy, S. Law, B. P. Whooley, A. Alexandrou, K. Chu et al., Atrial fibrillation after esophagectomy is a marker for postoperative morbidity and mortality, J Thorac Cardiovasc Surg, vol.126, issue.4, pp.1162-1169, 2003.

T. Ojima, M. Iwahashi, M. Nakamori, M. Nakamura, M. Katsuda et al., Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients, Surg Today, vol.44, issue.5, pp.839-886, 2014.

M. Bousamra, G. B. Haasler, and M. Parviz, A decade of experience with transthoracic and transhiatal esophagectomy, Am J Surg, vol.183, issue.2, pp.162-169, 2002.

C. Alexiou, Chylothorax following oesophagogastrectomy for malignant disease, Eur J Cardiothorac Surg, vol.14, issue.5, pp.460-466, 1998.

S. R. Markar, I. A. Smith, A. Karthikesalingam, and D. E. Low, The Clinical and Economic Costs of Delirium After Surgical Resection for Esophageal Malignancy: Ann Surg, 2013.

S. Schrader, K. E. Wellik, B. M. Demaerschalk, R. J. Caselli, B. K. Woodruff et al., Adjunctive Haloperidol Prophylaxis Reduces Postoperative Delirium Severity and Duration in At-Risk Elderly Patients: The Neurologist, vol.14, pp.134-141, 2008.

Y. Saito, H. Takeuchi, K. Fukuda, K. Suda, R. Nakamura et al., Size of recurrent laryngeal nerve as a new risk factor for postoperative vocal cord paralysis, Dis Esophagus [Internet], issue.6, p.31, 2018.

F. S. Atkinson, D. Hancock, P. Petocz, and J. C. Brand-miller,

E. Azzopardi, C. Lloyd, S. R. Teixeira, R. S. Conlan, and I. S. Whitaker, Clinical applications of amylase: Novel perspectives, Surgery, vol.160, issue.1, pp.26-37, 2016.

S. Andrianome, L. Hugueville, R. De-seze, and B. Selmaoui, Increasing levels of saliva alpha amylase in electrohypersensitive (EHS) patients, Int J Radiat Biol, vol.93, issue.8, pp.841-849, 2017.
URL : https://hal.archives-ouvertes.fr/ineris-01863166

L. Giulini, A. Dubecz, N. Solymosi, J. Tank, M. Renz et al., Prognostic Value of Chest-Tube Amylase Versus C-Reactive Protein as Screening Tool for Detection of Early Anastomotic Leaks After Ivor Lewis Esophagectomy, J Laparoendosc Adv Surg Tech, 2019.

, Feb, vol.29, issue.2, pp.192-199

G. H. Berkelmans, Diagnostic value of drain amylase for detecting intrathoracic leakage after esophagectomy, World J Gastroenterol, vol.21, issue.30, p.9118, 2015.

, Serment d'hippocrate

, Mon premier souci sera de rétablir, de préserver ou de promouvoir la santé dans tous ses éléments, physiques et mentaux, individuels et sociaux. Je respecterai toutes les personnes, leur autonomie et leur volonté, sans aucune discrimination selon leur état ou leurs convictions. J'interviendrai pour les protéger si elles sont affaiblies, vulnérables ou menacées dans leur intégrité ou leur dignité. Même sous la contrainte, Au moment d'être admis(e) à exercer la médecine, je promets et je jure d'être fidèle aux lois de l'honneur et de la probité

, Je ne tromperai jamais leur confiance et n'exploiterai pas le pouvoir hérité des circonstances pour forcer les consciences

, Je ne me laisserai pas influencer par la soif du gain ou la recherche de la gloire

, Je ferai tout pour soulager les souffrances. Je ne prolongerai pas abusivement les agonies. Je ne provoquerai jamais la mort délibérément. Je préserverai l'indépendance nécessaire à l'accomplissement de ma mission. Je n'entreprendrai rien qui dépasse mes compétences

, J'apporterai mon aide à mes confrères ainsi qu'à leurs familles dans l'adversité

, Que les hommes et mes confrères m'accordent leur estime si je suis fidèle à mes promesses

, Admis dans l'intérieur des maisons, mes yeux ne verront pas ce qui s'y passe, ma langue taira les secrets qui me seront confiés et mon état ne servira pas à corrompre les moeurs ni à favoriser le crime. Respectueux et reconnaissant envers mes MAÎTRES, En présence des Maîtres de cette FACULTE et de mes chers CONDISCIPLES, je promets et je jure d'être fidèle aux lois de l

, Que les HOMMES m'accordent leur estime si je suis fidèle à mes promesses. Que je sois couvert d'OPPROBRE et méprisé de mes confrères si j'y manque